Nuzenio

Tradingview Rapp

Tradingview Rapp entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 5 latest news signals 1 publisher sources 100/100 entity strength

Latest news

RAPP: RAP-219 shows robust efficacy in drug-resistant epilepsy, advancing to Phase 3 with strong financial backing - TradingViewTradingView · Wed, 05 Aug 2026 13:38:22 GMTRAPP: Net loss widened to $76.5M despite $20M in new licensing revenue; cash runway extends into 2029 - TradingViewTradingView · Wed, 05 Aug 2026 11:32:17 GMTRAPP: RAP-219 enters Phase 3 for seizures; Q2 net loss rises, cash runway extends to 2029 - TradingViewTradingView · Wed, 05 Aug 2026 11:19:34 GMTRAPP Q2'26 Earnings: EPS estimate is (0.96) USD - TradingViewTradingView · Wed, 05 Aug 2026 11:01:06 GMTRapport Therapeutics, Inc. Revenue Breakdown – NASDAQ:RAPP - TradingViewTradingView · Tue, 28 Jul 2026 00:55:58 GMT

Timeline

Wed, 05 Aug 2026 13:38:22 GMTRAPP: RAP-219 shows robust efficacy in drug-resistant epilepsy, advancing to Phase 3 with strong financial backing - TradingView
Wed, 05 Aug 2026 11:32:17 GMTRAPP: Net loss widened to $76.5M despite $20M in new licensing revenue; cash runway extends into 2029 - TradingView
Wed, 05 Aug 2026 11:19:34 GMTRAPP: RAP-219 enters Phase 3 for seizures; Q2 net loss rises, cash runway extends to 2029 - TradingView
Wed, 05 Aug 2026 11:01:06 GMTRAPP Q2'26 Earnings: EPS estimate is (0.96) USD - TradingView
Tue, 28 Jul 2026 00:55:58 GMTRapport Therapeutics, Inc. Revenue Breakdown – NASDAQ:RAPP - TradingView

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Tradingview Rapp.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.